The newest member of the Epionce Renew & Fortify step, Renewal Calming Cream is formulated to optimize andrestore hydration to the skin barrier to relieve the most stubborn symptoms associated with eczema and dry skin.This is the first Epionce product to fit under the FDA Over the Counter Skin Protectant monograph for eczema. A clinical study has shown the Renewal Calming Cream to provide needed relief for the symptoms of eczema.
Renews and fortifies the skin moisture barrier
Helps relieve and protect dry, itchy skin due to eczema and dry skin conditions
Formulated with colloidal oatmeal to soothe and calm
Advanced formula contains cholesterol and ceramics to protect the barrier
Created for the most sensitive skin types, EpionceMedical Barrier Cream is formulated with powerful complexes that restore the skin barrier. This therapeutic product is ideal for skin that is resistant to the sensitizers and preservatives found in standard moisturizers. Medical Barrier Cream is advanced skin therapy also suited for post-procedure healing and repair.
Most potent reparative. Rebuilds even the most compromised and damaged barrier
No sensitizers and preservatives or scent
This breakthrough formula has the highest concentration of EpiB complex to optimally restore the damaged barrier from aggressive skin products, procedures, and treatments
The FDA defines cosmetics as "articles...applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance." The majority of Epionce® products described on this website are intended to meet this definition. These Epionce® products and their associated statements have not been approved or evaluated by the FDA and are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition.
Epionce Ultra Shield Lotion SPF 50, Daily Shield Lotion Tinted SPF 50 and Renewal Calming Cream are considered over-the-counter drug products. They are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 C.F.R. Part 352.